Third, the Myeloma Research Alliance Risk Profile has also been developed for prognostication of transplant-ineligible myeloma patients; this risk score also included CRP level together with WHO performance status and the International Staging System [69]. This evidence concerns the gene CRP and plasma cell myeloma.